Harmonia Healthcare

Harmonia healthcare is a specialty women's health platform focused on treating underdiagnosed and undertreated female-specific conditions, with an initial emphasis on hyperemesis gravidarum (HG). HG is a severe form of nausea and vomiting during pregnancy that can lead to dehydration, weight loss, and nutritional deficiencies. Harmonia opened its first treatment center in Red Bank, New Jersey in May 2024, offering evidence-based care for HG patients. The company's approach includes medication and vitamin infusion, electrolyte replacement plans, prescription management, diagnostic bloodwork, and telehealth assistance. Harmonia's care model aims to reduce emergency room visits and healthcare costs associated with HG. The company leverages research on GDF15, the hormone identified as responsible for HG, to drive innovations in prognostics, prevention, and treatment. Harmonia's services are available to patients in New Jersey, with plans to open a New York City location in fall 2024. The company operates Monday through Friday from nine am to five pm and offers telehealth appointments for New Jersey residents.

Key customers and partnerships

Harmonia healthcare works in collaboration with patients' existing healthcare providers, including obstetricians, midwives, and doulas, to provide comprehensive care. The company's model has shown a 95% reduction in ER visits and a 90% decrease in total cost of care for HG patients. Harmonia is also partnering with researchers and pharmaceutical companies to conduct clinical trials on potential new treatments for HG. The company has an advisory relationship with the co-founder of Alabama's Morning Sickness Clinic, which claims similar reductions in ER visits and care costs. Harmonia was planning to work with commercial and Medicaid insurance plans to expand access to their services.